(Q77766048)

English

Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group

scientific article published on 01 May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

based on heuristic

inferred from title

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

127

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

537-544

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Soft drugs: principles and methods for the design of safe drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Failure to detect systemic levels, and effects of loteprednol etabonate and its metabolite, PJ-91, following chronic ocular administration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900034-3

7 January 2021

Identifiers

10.1016/S0002-9394(99)00034-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10334346%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77766048&oldid=1687640360"